Medidata, Icon partner on electronic patient-reported outcomes

By Zachary Brennan contact

- Last updated on GMT

Related tags: Clinical trial, Clinical research

Medidata, Icon partner on electronic patient-reported outcomes
Cloud-based solution provider Medidata and CRO Icon have launched a joint initiative to bring new efficiency to the administration of electronic patient-reported outcomes (ePROs) in clinical trials. 

The collaboration will combine Medidata’s cloud-based technology with Icon’s ready-to-use, pre-validated surveys, which provides sponsors with an ePRO solution that could reduce costs, save time and enhance patient engagement.

Anne Zielinski, global lead for Medidata’s cloud, told that the collaboration builds on a 10-year relationship between the two companies. “The partnership announced today was directly related to Icon’s acquisition of Oxford Outcomes, which is a leader in providing guidance around and testing for validated psychometric instruments that can collect data from patients in clinical trials​.”

Medidata introduced a mobile app that allows patients to input data onto smartphones and tablets, and from which patients will be able to complete the validated questionnaires.  

What we’re doing now with Icon is building these questionnaires into a library and pre-validating them to make the process more efficient​,” Zielinski said.

Available on any iOS device and automatically unified with Medidata’s platform, Patient Cloud provides electronic patient questionnaire and diary functionality to simplify the setup process for research organizations, which may have been previously burdened by customized software and proprietary devices.

In addition to general questionnaires, “there are also probably about 15-20% of these types of questionnaires that are specific to a therapeutic area – haemophilia or Crohn’s disease, for example – and they’re used across a broad range of therapeutic areas​,” Zielinski said. “What we’re seeing is tremendous growth in these types of questionnaires…we’re continuing to build a library based on sponsor requests​.”

As far as savings is considered, Zielinski couldn’t put an estimate on the amount of time a sponsor may save, but she said “the quality of data collected is tremendously higher​” because the data can be deployed on smartphones and tablets, which means the source data doesn’t need to be verified or transcribed – “it’s available immediately for review and in many cases can have an impact on the safety of subjects…we anticipate that the safety of patients will be increased​.”

And in simplifying the data capture and patient participation processes, Medidata claims its ePRO solution is transforming the clinical trial experience for study participants at a time when capturing the patient voice is becoming increasingly important.

We’re thrilled to be expanding this partnership and share ICON’s commitment to bringing the voice of the patient to clinical research​,” said Glen de Vries, Medidata’s president. “Together, we’re changing how the industry conducts clinical trials by making ePROs applicable to a wider array of studies, reducing the work required to use them and eliminating pain points such as equivalencies and other complicated processes​.”

Related news

Show more

Related products

show more

The Essential Clinical Development Resource Center

The Essential Clinical Development Resource Center

Data Management Solution Center | 05-Mar-2020 | Data Sheet

Clinical trials are becoming increasingly complex with oversight workloads increasing too. A recent survey based study conducted by Medidata in association...

Infographic:Transforming Data Capture & Management

Infographic:Transforming Data Capture & Management

Data Management Solution Center | 05-Mar-2020 | Infographic

Is your clinical study's data capture and management processes efficient? Medidata Rave Clinical Cloud is the only industry platform that creates...

Electronic Informed Consent and Global Regulation

Electronic Informed Consent and Global Regulation

Data Management Solution Center | 05-Mar-2020 | Technical / White Paper

Medidata is conducting an on-going study to understand global regulatory positions, adoption and variability regarding eConsent. The benefits of eConsent...

De-risk Go/No Go Product Development Decisions

De-risk Go/No Go Product Development Decisions

Data Management Solution Center | 05-Mar-2020 | Technical / White Paper

Learn how synthetic controls enable new insights for oncology clinical development and mitigates go/no-go decision risk. Synthetic control data can assist...

Related suppliers

Follow us


View more